FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ondansetron Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 04/10/2018
»Therapeutic Categories: Gastroenterology

Expand all

Athenex Pharmaceutical Division, LLC (Athenex) (Revised 06/20/2018)

Company Contact Information:
855-273-0154

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL 2mL vial (NDC 70860-776-02) Available Demand increase for the drug
2 mg/mL 20mL vial (NDC 70860-777-20) Available Demand increase for the drug

AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.) (Reverified 06/13/2018)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL, 2 mL vial, 25 count (NDC 55150-125-02) Currently on backorder, next shipment TBD Intermittent backorders expected Demand increase for the drug
2 mg/mL, 20 mL vial, 1 count (NDC 55150-126-20) Currently on backorder, next shipment TBD Intermittent backorders expected Demand increase for the drug

Fresenius Kabi USA, LLC (Revised 06/26/2018)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Single dose, amber vial, 4 mg per 2 mL (NDC 63323-373-02) Backordered. Next release anticipated August 2018. Demand increase for the drug
Multi dose, amber vial, 40 mg per 20 mL (NDC 63323-374-20) Backordered. Next release date not available at this time. Demand increase for the drug
Single dose, Simplist syringe, 4 mg per 2 mL (NDC 76045-103-20) Backordered. Next release anticipated September 2018. Demand increase for the drug

Heritage Pharma (New 04/11/2018)

Company Contact Information:
866-901-1230

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Inj4mg/2mL, 25 (NDC 23155-549-31) Limited supply available Demand increase for the drug
PPRx4mg/2mL (NDC 23155-548-41) Limited supply available Demand increase for the drug
PPRx4mg/2mL (NDC 23155-548-42) Limited supply available Demand increase for the drug
4mg/2mL, 10 (NDC 23155-547-41 ) Limited supply available Demand increase for the drug

Hospira, Inc. (Revised 06/29/2018)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg/20 mL (2 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-4759-01) Next Delivery: October 2018; Estimated Recovery: December 2018 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
4 mg/2 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-4755-03) Next Delivery: July 2018; Estimated Recovery: September 2018 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
4 mg/2 mL (2 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1120-12) Next Delivery and Estimated Recovery: 2019 Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter

Other

West-Ward Pharmaceuticals (Revised 07/06/2018)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL, 20 mL vial (NDC 0143-9890-01) West-Ward has available inventory. Additional lots are scheduled to be manufactured and available in the July/August 2018 timeframe. Product will be made available as it is released. Demand increase for the drug
2 mg/mL, 2 mL vial (NDC 0641-6078-25) This presentation is temporarily on backorder. Additional lots are scheduled to be manufactured and available in the July/August 2018 timeframe. Product will be made available as it is released. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English